These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31915880)
1. [Exosomes: potential liquid biopsy in head and neck cancer]. Theodoraki MN; Ludwig S HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC). Ebnoether E; Muller L Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189 [No Abstract] [Full Text] [Related]
5. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer. Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240 [TBL] [Abstract][Full Text] [Related]
6. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer. Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374 [TBL] [Abstract][Full Text] [Related]
7. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation. Qadir F; Aziz MA; Sari CP; Ma H; Dai H; Wang X; Raithatha D; Da Silva LGL; Hussain M; Poorkasreiy SP; Hutchison IL; Waseem A; Teh MT Mol Cancer; 2018 Jul; 17(1):97. PubMed ID: 30008265 [TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs). Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757 [TBL] [Abstract][Full Text] [Related]
9. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma. Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461 [TBL] [Abstract][Full Text] [Related]
10. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer. Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274 [TBL] [Abstract][Full Text] [Related]
11. Proteomes of exosomes from HPV(+) or HPV(-) head and neck cancer cells: differential enrichment in immunoregulatory proteins. Ludwig S; Marczak L; Sharma P; Abramowicz A; Gawin M; Widlak P; Whiteside TL; Pietrowska M Oncoimmunology; 2019; 8(7):1593808. PubMed ID: 31143515 [TBL] [Abstract][Full Text] [Related]
12. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence. Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863 [TBL] [Abstract][Full Text] [Related]
14. The development of a liquid biopsy for head and neck cancers. Schmidt H; Kulasinghe A; Kenny L; Punyadeera C Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098 [TBL] [Abstract][Full Text] [Related]
15. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers. Raulf N; Lucarelli P; Thavaraj S; Brown S; Vicencio JM; Sauter T; Tavassoli M Eur J Cancer; 2018 Oct; 102():52-68. PubMed ID: 30142511 [TBL] [Abstract][Full Text] [Related]
16. Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP. Coray M; Göldi V; Schmid L; Benecke L; Figueiró F; Muller L Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430925 [TBL] [Abstract][Full Text] [Related]
17. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update. Whiteside TL Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709 [No Abstract] [Full Text] [Related]
18. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513 [No Abstract] [Full Text] [Related]